Back to search
FDAFDA · Food and drugs·Recall number D-0944-2018

fentaNYL 3 mcg/mL, 0.1% Bupivacaine, Fentanyl Citrate, USP 750 mcg, Bupivacaine HCL PF, USP, 250 mg, 0.9% Sodium Chloride, USP QS 250 mL. Volume: 250mL. Single dose Cassette. For: Methodist St. John Hospital, By: Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054. NDC 15082-250-87

Published July 25, 2018 · Recall initiated: June 12, 2018

Summary

FDA records drug Class II recall D-0944-2018, published July 25, 2018 and initiated June 12, 2018. Recalling firm: Avella of Deer Valley, Inc. Store 38; Status: Terminated; Reported quantity: 15 cassettes; Lot: Lot #: 5/14/18 0913 320-25087Y, BUD 6/28/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Potential leakage of bags.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Avella of Deer Valley, Inc. Store 38
Distributor
Nationwide in the USA
Lot
Lot #: 5/14/18 0913 320-25087Y, BUD 6/28/2018.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was fentaNYL 3 mcg/mL, 0.1% Bupivacaine, Fentanyl Citrate, USP 750 mcg, Bupivacaine HCL PF, USP, 250 mg, 0.9% Sodium Chloride, USP QS 250 mL. Volume: 250mL. Single dose Cassette. For: Methodist St. John Hospital, By: Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054. NDC 15082-250-87 recalled?

Yes. FDA published recall D-0944-2018 on July 25, 2018. Reported hazard: Lack of Assurance of Sterility: Potential leakage of bags.

What should I do if I have this product?

Voluntary: Firm initiated · Letter